Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, B-Cell
×
ibrutinib
×
Clear all
Filters
3
NCT05254743
2026-03-12
BRUIN-CLL-314
Eli Lilly and Company
Phase 3
Recruiting
662 enrolled
NCT04608318
2024-12-31
CLL17
German CLL Study Group
Phase 3
Active not recruiting
897 enrolled